Advertisement
Letter to the editor| Volume 258, P49-50, November 2021

When cascade testing for familial variant seems inadequate to provide clinically actionable information for blood relatives

      Dear Editor,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cancer Genetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Whitworth J
        • Skytte AB
        • Sunde L
        • Lim DH
        • Arends MJ
        • Happerfield L
        • Frayling IM
        • van Minkelen R
        • Woodward ER
        • Tischkowitz MD
        • Maher ER
        Multilocus inherited neoplasia alleles syndrome: a case series and review.
        JAMA Oncol. 2016; 2: 373-379
        • Stradella A
        • Del Valle J
        • Rofes P
        • Feliubadalo L
        • Grau Garces E
        • Velasco A
        • Gonzalez S
        • Vargas G
        • Izquierdo A
        • Campos O
        • Tornero E
        • Navarro M
        • Balmana-Gelpi J
        • Capella G
        • Pineda M
        • Brunet J
        • Lazaro C
        Does multilocus inherited neoplasia alleles syndrome have severe clinical expression?.
        J Med Genet. 2019; 56: 521-525
        • Fostira F
        • Kostantopoulou I
        • Apostolou P
        • Papamentzelopoulou MS
        • Papadimitriou C
        • Faliakou E
        • Christodoulou C
        • Boukovinas I
        • Razis E
        • Tryfonopoulos D
        • Barbounis V
        • Vagena A
        • Vlachos IS
        • Kalfakakou D
        • Fountzilas G
        • Yannoukakos D
        One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene.
        J Med Genet. 2020; 57: 53-61
        • Papamentzelopoulou M
        • Apostolou P
        • Fostira F
        • Dimitrakakis C
        • Loutradis D
        • Fountzilas G
        • Yannoukakos D
        • Konstantopoulou I
        Prevalence and founder effect of the BRCA1 p.(Val1833Met) variant in the Greek population, with further evidence for pathogenicity and risk modification.
        Cancer Genet. 2019; 237: 90-96